Department of Transfusion Medicine

2019 DTM Symposiums

38th Annual Immunohematology & Blood Transfusion Symposium

Jay Epstein receiving an award from Dr. Harvey G. Klein
Dr. Jay Epstein, of the FDA, receives the Richard J. Davey Award from Dr. Harvey G. Klein, former chief of the NIH Clinical Center Department of Transfusion Medicine.
Kamille West speaking
Dr. Kamille A. West, NIH Clinical Center Department of Transfusion Medicine Blood Services Section chief, provides an update on the status of granulocyte transfusions.
Michael Murphy speaking
Dr. Michael F. Murphy, AABB President, kicks off the Red Cell Genotyping Patient First Symposium meeting with his keynote address.

A record breaking number of people came to the 38th Annual Immunohematology & Blood Transfusion Symposium Sept. 19 in the NIH Clinical Center. The audience heard presentations that educated participants about transfusion medicine practices and guidelines in Europe and global awareness of blood availability and safety worldwide.

Esteemed presenters from the U.S. Food and Drug Administration, the American Red Cross, Johns Hopkins University School of Medicine, and the National Institutes of Health discussed continuing transfusion medicine advancements and persistent concerns.

The day ended with a presentation by Dr. John Tisdale, from the National Heart, Lung, and Blood Institute, entitled "Curative Therapies for Hemoglobinopathies."

9th Annual Red Cell Genotyping Patient First Symposium

The 9th Annual Red Cell Genotyping Patient First Symposium's keynote address was given by Dr. Michael F. Murphy, who is the current president of the professional organization, the AABB. This was the beginning of an impressive line-up of speakers to inform the audience of the latest technologies, applications, and values of red blood cell genotyping when applied to patient care and monitoring.

AABB's recipient of the Karl Landsteiner Award, Dr. Fumiichiro Yamamoto, gave the last presentation entitled "How is all began in the 1980's: MN, ABO and Rh, and where we stand today." His talk left the audience with a good understand of discovery and areas to consider for moving into the future.

Christopher Tormey speaking
Dr. Christopher A. Tormey, from Yale University, delivers a presentation addressing RBC alloimmunization and the Red Cell Genotyping Patient First Symposium.

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 04/29/2022

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at